WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...

As millions of Americans hit the road or take to the skies for the holidays, another seasonal traveler is picking up speed: ...

Fact check - Patients who have been vaccinated against Covid-19 do not need to undergo routine D-dimer testing.

“Vitamin D deficiency continues to be a worldwide health problem. It’s estimated upwards of 60% of the world’s population is ...

What causes chronic fatigue syndrome? From viral infections to immune disorders, discover the triggers and symptoms behind ...

The authors of a new Australian study say they have identified a set of 32 genetic variants that increase the likelihood of ...

A grieving daughter is keen to raise awareness of the simple test for prostate cancer, after losing her father to the disease.

Global Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through ...

Source: How Zimbabwe’s mushrooming medical laboratories are endangering lives  – CITEZW Lab technicians at Omnipath ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, Stanford University researchers found, shedding light on a mechanism that’s fueled ...